The aim of this study was to determine the effects of supplementing Lysine (Lys) at on growth performance and immune responses of broiler chickens challenged with infectious bursal disease (IBD) and estimation of Lys requirement based on different response criterions. A total of 400-day-old male broiler chicks were assigned to eight dietary treatments. Chickens were fed by eight graded levels of Lys (0.8 National Research Council (NRC) (0.75% of diet), 0.9 NRC (0.85% of diet), NRC (0.94 of diet), 1.1 NRC (1.03% of diet), 1.2 NRC (1.13% of diet), 1.3 NRC (1.22% of diet), 1.5 NRC (1.41% of diet) and 1.8 NRC (1.69% of diet)) from day 21 to 42 of age. On day 28, all birds were challenged with a commercial live-IBDV vaccine. Body weight gains (BWG), feed conversion ratio (FCR) and carcass characterization (breast, thigh and fat pad percentage) were significantly influenced by dietary Lys levels. With increasing Lys level up to 1.22% of diet, performance improved significantly and with higher than this level decreased. Antibody titre against IBD was influenced by Lys levels. On 7 and 14 days after IBD challenge, antibody titre against IBD of broilers that receive diet that contain Lys higher than NRC recommendation wwas significantly higher than those receive lower level and the highest antibody level found in 1.22% Lys in diet. The highest (1.251990.0441) and the lowest (1.040890.11) Lys requirements with straightbroken line analysis were estimated for immune response and carcass efficiency percentage, respectively. The results obtained on the present study indicated that Lys requirements of broiler based on recommendation of NRC are not sufficient to meet the requirement of the new commercial poultry and commercial broiler companies under non-hygienic condition.